Delay in the progression of low-risk prostate cancer: Rationale and design of the Reduction by Dutasteride of Clinical Progression Events in Expectant Management (REDEEM) trial
Titel:
Delay in the progression of low-risk prostate cancer: Rationale and design of the Reduction by Dutasteride of Clinical Progression Events in Expectant Management (REDEEM) trial
Auteur:
Fleshner, Neil Gomella, Leonard G. Cookson, Michael S. Finelli, Antonio Evans, Andrew Taneja, Samir S. Scott Lucia, M. Wolford, Eric Somerville, Matthew C. Rittmaster, Roger